 Limitations thrombolytic therapy acute myocardial infarction congestive heart failure cardiogenic shock many quarter patients thrombolytic therapy present congestive heart failure cardiogenic shock thrombolytic therapy infarct size preserve ventricular ejection fraction decrease mortality subgroups patients apparent benefit patients clinical ventricular dysfunction lack correlation ejection fraction measurements left ventricular dysfunction exercise time cardiac output pressures activation neurohumoral system regional perfusion abnormalities paradox perfusion rates reocclusion rates mechanical complications infarction findings Preliminary data indicate emergency coronary angioplasty bypass graft surgery survival patients cardiogenic shock findings restoration infarct artery patency important patients clinical ventricular dysfunction additional studies patients potential benefit new thrombolytic strategies inotropic vasodilator agents intraaortic balloon counterpulsation coronary blood flow improving reperfusion rates Currently acute mechanical revascularization patients congestive heart failure hypotension tachycardia patients cardiogenic shock